These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38228356)

  • 21. Illness risk following rapid versus gradual discontinuation of antidepressants.
    Baldessarini RJ; Tondo L; Ghiani C; Lepri B
    Am J Psychiatry; 2010 Aug; 167(8):934-41. PubMed ID: 20478876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barriers and Facilitating Factors of Adherence to Antidepressant Treatments: An Exploratory Qualitative Study with Patients and Psychiatrists.
    González de León B; Abt-Sacks A; Acosta Artiles FJ; Del Pino-Sedeño T; Ramos-García V; Rodríguez Álvarez C; Bejarano-Quisoboni D; Trujillo-Martín MM
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barriers and facilitators to discontinuing antidepressant use: A systematic review and thematic synthesis.
    Maund E; Dewar-Haggart R; Williams S; Bowers H; Geraghty AWA; Leydon G; May C; Dawson S; Kendrick T
    J Affect Disord; 2019 Feb; 245():38-62. PubMed ID: 30366236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why do patients discontinue antidepressant therapy early? A qualitative study.
    Jaffray M; Cardy AH; Reid IC; Cameron IM
    Eur J Gen Pract; 2014 Sep; 20(3):167-73. PubMed ID: 24160364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospital patients' perceptions during treatment and early discontinuation of serotonin selective reuptake inhibitor antidepressants.
    Woolley SB; Fredman L; Goethe JW; Lincoln AK; Heeren T
    J Clin Psychopharmacol; 2010 Dec; 30(6):716-9. PubMed ID: 21105288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Causes of drug discontinuation in patients with major depressive disorder in China.
    Zhu Y; Wu Z; Sie O; Cai Y; Huang J; Liu H; Yao Y; Niu Z; Wu X; Shi Y; Zhang C; Liu T; Rong H; Yang H; Peng D; Fang Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109755. PubMed ID: 31454555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experience of antidepressant use and discontinuation: A qualitative synthesis of the evidence.
    Crowe M; Inder M; McCall C
    J Psychiatr Ment Health Nurs; 2023 Feb; 30(1):21-34. PubMed ID: 35713005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient experiences of taking antidepressants for depression: a secondary qualitative analysis.
    Anderson C; Roy T
    Res Social Adm Pharm; 2013; 9(6):884-902. PubMed ID: 23219056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study].
    Müller A; Konigorski S; Meißner C; Fadai T; Warren CV; Falkenberg I; Kircher T; Nestoriuc Y
    BMC Psychiatry; 2023 Oct; 23(1):749. PubMed ID: 37833651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis.
    Gauthier G; Guérin A; Zhdanava M; Jacobson W; Nomikos G; Merikle E; François C; Perez V
    BMC Psychiatry; 2017 Jun; 17(1):222. PubMed ID: 28629442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial.
    Bockting CLH; Klein NS; Elgersma HJ; van Rijsbergen GD; Slofstra C; Ormel J; Buskens E; Dekker J; de Jong PJ; Nolen WA; Schene AH; Hollon SD; Burger H
    Lancet Psychiatry; 2018 May; 5(5):401-410. PubMed ID: 29625762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Digital Intervention for Primary Care Practitioners to Support Antidepressant Discontinuation (Advisor for Health Professionals): Development Study.
    Bowers H; Kendrick T; van Ginneken N; Glowacka M; Williams S; Leydon GM; May C; Dowrick C; Moncrieff J; Johnson CF; Moore M; Laine R; Geraghty AWA
    J Med Internet Res; 2021 Jul; 23(7):e25537. PubMed ID: 34269688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational Mechanisms of Effort and Reward Decisions in Patients With Depression and Their Association With Relapse After Antidepressant Discontinuation.
    Berwian IM; Wenzel JG; Collins AGE; Seifritz E; Stephan KE; Walter H; Huys QJM
    JAMA Psychiatry; 2020 May; 77(5):513-522. PubMed ID: 32074255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
    Ghaemi SN; Ostacher MM; El-Mallakh RS; Borrelli D; Baldassano CF; Kelley ME; Filkowski MM; Hennen J; Sachs GS; Goodwin FK; Baldessarini RJ
    J Clin Psychiatry; 2010 Apr; 71(4):372-80. PubMed ID: 20409444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events.
    Demyttenaere K; Enzlin P; Dewé W; Boulanger B; De Bie J; De Troyer W; Mesters P
    J Clin Psychiatry; 2001; 62 Suppl 22():30-3. PubMed ID: 11599645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective serotonin reuptake inhibitor discontinuation: side effects and other factors that influence medication adherence.
    Goethe JW; Woolley SB; Cardoni AA; Woznicki BA; Piez DA
    J Clin Psychopharmacol; 2007 Oct; 27(5):451-8. PubMed ID: 17873676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Internet and Telephone Support for Discontinuing Long-Term Antidepressants: The REDUCE Cluster Randomized Trial.
    Kendrick T; Stuart B; Bowers H; Haji Sadeghi M; Page H; Dowrick C; Moore M; Gabbay M; Leydon GM; Yao GL; Little P; Griffiths G; Lewis G; May C; Moncrieff J; Johnson CF; Macleod U; Gilbody S; Dewar-Haggart R; Williams S; O'Brien W; Tiwari R; Woods C; Patel T; Khan N; van Ginneken N; Din A; Reidy C; Lucier R; Palmer B; Becque T; van Leeuwen E; Zhu S; Geraghty AWA
    JAMA Netw Open; 2024 Jun; 7(6):e2418383. PubMed ID: 38913372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial.
    Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Brejcha C; Cardy J; Causley A; Cowderoy S; Evans A; Gradinger F; Kaur S; Lanham P; Morant N; Richards J; Shah P; Sutton H; Vicary R; Weaver A; Wilks J; Williams M; Taylor RS; Byford S
    Lancet; 2015 Jul; 386(9988):63-73. PubMed ID: 25907157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reasons for antidepressant nonadherence among veterans treated in primary care clinics.
    Fortney JC; Pyne JM; Edlund MJ; Stecker T; Mittal D; Robinson DE; Henderson KL
    J Clin Psychiatry; 2011 Jun; 72(6):827-34. PubMed ID: 21208579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.
    Vega C; Becker RV; Mucha L; Lorenz BH; Eaddy MT; Ogbonnaya AO
    Curr Med Res Opin; 2017 Oct; 33(10):1879-1889. PubMed ID: 28644095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.